Plasma and Tissue Specific miRNA Expression Pattern and Functional Analysis Associated to Colorectal Cancer Patients
Authors:
- Roxana CojocneanuRCRoxana Cojocneanu
- Cornelia BraicuCornelia Braicu
- Lajos RadulyLRLajos Raduly
- Ancuta JurjAncuta Jurj
- Oana ZanoagaOZOana Zanoaga
- Lorand MagdoLMLorand Magdo
- Alexandru IrimieAIAlexandru Irimie
- Mihai-Stefan MuresanMMMihai-Stefan Muresan
- Calin IonescuCICalin Ionescu
- Mircea GrigorescuMGMircea Grigorescu
- Ioana Berindan-NeagoeIoana Berindan-Neagoe
Open Access
Abstract
An increasing number of studies suggest the implication of microRNAs (miRNAs) in colorectal (CRC) carcinogenesis and disease progression. Nevertheless, the basic mechanism is not yet clear. We determined plasma miRNA expression levels using Agilent microarray technology followed by overlapping with The Cancer Genome Atlas (TCGA) tissue data and a qRT-PCR validation step and analysis of the altered miRNA signatures to emphasize new mechanistic insights. For TGCA dataset, we identified 156 altered miRNAs (79 downregulated and 77 upregulated) in colorectal tissue samples versus normal tissue. The microarray experiment is based on 16 control samples, 38 CRC plasma samples from colorectal cancer patients who have not undergone chemotherapy, and 17 chemo-treated samples. In the case of the analysis of CRC cancer versus healthy control we identified 359 altered miRNAs (214 downregulated and 60 upregulated), considering as the cutoff value a fold-change of ±1.5 and p < 0.01. An additional microarray analysis was performed on plasma from untreated colorectal cancer (n = 38) and chemotherapy-treated colorectal cancer patients (n = 17), which revealed 15 downregulated miRNAs and 53 upregulated miRNAs, demonstrating that the plasma miRNA pattern is affected by chemotherapy and emphasizing important regulators of drug resistance mechanisms. For the validation of the microarray data, we selected a panel of 4 miRNAs from the common miRNA signatures for colon and rectal cancer (miR-642b-3p, miR-195-5p and miR-4741). At the tissue level, the expression levels were in agreement with those observed in colorectal plasma. miR-1228-3p, the top upregulated miRNA in CRC, was chosen to be validated on tissue and plasma samples, as it was demonstrated to be downregulated at tissue level in our patient cohort. This was confirmed by TCGA data and was one example of ta ranscript that has a different expression level between tumor tissue and plasma. Developing more efficient investigation methods will help explain the mechanisms responsible for miRNAs released in biofluids, which is the most upregulated transcript in colorectal plasma samples and which can function as a prediction tool within the oncological field.Keywords
This publication has 43 references indexed in Scilit:
- Autophagy selectively regulates miRNA homeostasisAutophagy, 2013
- Selective autophagy degrades DICER and AGO2 and regulates miRNA activityNature Cell Biology, 2012
- The Rectal Cancer microRNAome – microRNA Expression in Rectal Cancer and Matched Normal MucosaClinical Cancer Research, 2012
- A Systems Biology Approach Identifies SART1 as a Novel Determinant of Both 5-Fluorouracil and SN38 Drug Resistance in Colorectal CancerMolecular Cancer Therapeutics, 2012
- Early Detection of Colon Cancer—The Kaiser Permanente Northwest 30-Year History: How Do We Measure Success? Is It the Test, the Number of Tests, the Stage, or the Percentage of Screen-Detected Patients?The Permanente Journal, 2011
- The molecular biology of colorectal carcinoma and its implications: A reviewThe Surgeon, 2011
- Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomasVirchows Archiv, 2011
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour typesEuropean Journal of Cancer, 2010
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell linesOncogene, 2005